News & Updates

Adjuvant treatment with aspirin appears to provide some protection in patients with resected, PIK3CA-mutant stage II and III colon cancer, demonstrating a clinically significant improvement (43 percent) in disease-free survival (DFS), suggests a study presented at ESMO Congress 2024.

The risk of myocarditis appears to be elevated among patients with inflammatory bowel disease (IBD) for ≥20 years following diagnosis, suggests a study in Sweden. However, absolute risks remain low.

A history of upper gastrointestinal (GI) mucosal damage, such as peptic ulcer disease and erosions, has been associated with subsequent incidence of Parkinson’s disease (PD) in a study.